Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge [Yahoo! Finance]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
the screening of patients seeking Ozempic-style ?weight loss drugs for apnea, calling the GLP-1 boom a lift, not a ?threat, to sales. ResMed, founded in Australia but now headquartered in California and which gains most of its revenue in ?the U.S, last week reported an 11% jump in second-quarter profit. Weight-loss drugs had helped sales of its devices that treat sleep apnea - a common disorder characterised by brief interruptions of breathing during sleep. Rapid uptake of GLP-1 injections in the U.S. is driving patients into primary care clinics where ?they are typically assessed for comorbidities, ?including sleep apnea, to get health subsidies. "It's a tailwind," Mick Farrell, chief executive of the maker of continuous positive airway pressure (CPAP) machines, said in ?an interview on Tuesday. "The question is how much of that tailwind can we capture," he said. "We're starting in the U.S. because that's where pharma does (direct-to-consumer) advertising ... but we'll contin
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- ResMed Inc. (RMD): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- ResMed (NYSE:RMD) had its "buy" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell [Seeking Alpha]Seeking Alpha
- ResMed (NYSE:RMD) had its price target raised by analysts at Wells Fargo & Company from $265.00 to $270.00. They now have an "equal weight" rating on the stock.MarketBeat
- ResMed (NYSE:RMD) was given a new $281.00 price target on by analysts at Robert W. Baird.MarketBeat
RMD
Earnings
- 1/29/26 - Beat
RMD
Sec Filings
- 2/4/26 - Form 144
- 2/4/26 - Form 144
- 2/3/26 - Form 4
- RMD's page on the SEC website